Tirzepatide

What is Tirzepatide

Tirzepatide is a once-weekly injectable medication available under the brand names Mounjaro and Zepbound. Mounjaro is FDA approved for type 2 diabetes and Zepbound is approved for weight management. Tirzepatide is a GLP-1 and GIP receptor agonist that mimics two hormones: glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP). These hormones are produced naturally in the body and help regulate appetite and food intake by working on both the gut and the brain.

How does Tirzepatide work

What makes Tirzepatide unique is that it doesn’t just target one hormone, it targets two. By mimicking the effects of both GLP-1 and GIP, tirzepatide has a powerful combined effect in your body. It slows digestion and decreases appetite, which can help individuals eat less and lose weight, and stimulates the pancreas to produce more insulin when you eat, making it effective at managing blood sugar.

Is Tirzepatide covered by insurance

Your Clinic Care Team will work directly with your insurance provider to help you navigate your coverage of this GLP-1 medication. The cost of the medication is not included as part of the Peptides Global Lab membership and insurance coverage may vary.

At this time, our Insurance Coordinators can only work with commercial insurance plans.

This means that all members with government-sponsored insurance, on a Kaiser plan, or who do not have insurance will either have to pay out-of-pocket for a GLP-1 medication or use one of the prescription options that do not require insurance and are fully covered in the cost of Peptides Global Lab Clinic membership.

If you continue, you will be evaluated for the membership-included medications to see if your Clinician thinks you’re a good fit, or choose to pay without insurance for GLP-1 medications.